Lomitapide mesylate

Cat. No.: 0225LY-1244

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Add to basket

Product Overview

Description: Lomitapide mesylate is the methanesulfonic acid salt form of lomitapide, which serves as a small molecule inhibitor of MTP.

Synonym: BMS-201038 mesylate; AEGR-733 mesylate; 202914-84-9; BMS 201038-04; Aegr-733 mesilate; BMS-201038-04; Lomitapide (mesylate); Lomitapide mesilate; 9H-Fluorene-9-carboxamide, N-(2,2,2-trifluoroethyl)-9-(4-(4-(((4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-1-piperidinyl)butyl)-, methanesulfonate; N-(2,2,2-trifluoroethyl)-9-(4-(4-(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamido)piperidin-1-yl)butyl)-9H-fluorene-9-carboxamide methanesulfonate; N-(2,2,2-trifluoroethyl)-9-(4-(4-(4'-(trifluoromethyl)biphenyl-2-ylcarboxamido)piperidin-1-yl)butyl)-9H-fluorene-9-carboxamide methanesulfonate

CAS No.: 202914-84-9

Compound CID: 11274333

Formula: C₄₀H₄₁F₆N₃O₅S

Formula Weight: 789.83

Specification

Targets&IC50: MTP: 8 nM

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Lomitapide mesylate can be used in lipid metabolism research to study the systemic reduction of apolipoprotein B-containing lipoproteins.